We are live on ! Find out more
AllianceBernstein

AllianceBernstein Portfolio holdings

AUM $309B
1-Year Est. Return 23.92%
 

AllianceBernstein (AB), formed in 2000 through the merger of Alliance Capital and Bernstein, is a global asset management firm headquartered in Nashville, Tennessee, managing over $759 billion in assets as of late 2024 for institutional investors, financial advisors, and individuals. Known for its research-driven approach, AB offers a diverse range of investment strategies, including equities, fixed income, alternatives, and multi-asset solutions, with a strong emphasis on active management and ESG (environmental, social, governance) integration. The firm, which relocated its headquarters from New York City to Nashville in 2021, operates globally with significant operations in New York, London, and Asia, leveraging its Bernstein Research arm for deep market insights. With a workforce of over 4,700 and a partnership structure led by CEO Seth Bernstein, AB combines a legacy of rigorous analysis with a modern focus on sustainable investing and client outcomes.

This Fund
S&P 500
This Quarter Est. Return
+4.56%
1 Year Est. Return
+23.92%
3 Year Est. Return
+92.38%
5 Year Est. Return
+118.97%
10 Year Est. Return
+515.32%
AUM
$295B
AUM Growth
-$3.08B
Cap. Flow
-$7.58B
Cap. Flow %
-2.57%
Top 10 Hldgs %
30.42%
Holding
3,298
New
67
Increased
918
Reduced
1,605
Closed
77

Top Sells

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$1.6B
2
DIS icon
Walt Disney
DIS
+$795M
3
IDXX icon
Idexx Laboratories
IDXX
+$692M
4
ZTS icon
Zoetis
ZTS
+$640M
5
MSFT icon
Microsoft
MSFT
+$615M

Sector Composition

Rank Sector Weight
1 Technology 29.02%
2 Healthcare 12.31%
3 Consumer Discretionary 11.7%
4 Financials 11.01%
5 Communication Services 9.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LNAI
3201
Lunai Bioworks
LNAI
$10.6M
$31.7K ﹤0.01%
474
CMPX icon
3202
Compass Therapeutics
CMPX
$373M
$31.1K ﹤0.01%
21,440
-2,740
-11% -$4.55K
VERU icon
3203
Veru
VERU
$36.1M
$29.6K ﹤0.01%
4,544
-50
-1% -$371
TDUP icon
3204
ThredUp
TDUP
$736M
$28.2K ﹤0.01%
20,310
KG
3205
Kestrel Group
KG
$71.3M
$26.2K ﹤0.01%
777
LCTX icon
3206
Lineage Cell Therapeutics
LCTX
$257M
$23.4K ﹤0.01%
46,580
SBDS
3207
DELISTED
Solo Brands Inc
SBDS
$22.4K ﹤0.01%
491
PYXS icon
3208
Pyxis Oncology
PYXS
$165M
$21K ﹤0.01%
13,470
IPSC icon
3209
Century Therapeutics
IPSC
$381M
$20.2K ﹤0.01%
20,020
TLRY icon
3210
Tilray
TLRY
$479M
$19.6K ﹤0.01%
1,470
-1
-0.1% -$15
STI icon
3211
Solidion Technology
STI
$56.1M
$19.2K ﹤0.01%
550
MAPS
3212
DELISTED
WM TECHNOLOGY INC A
MAPS
$18.6K ﹤0.01%
13,500
ATNM icon
3213
Actinium Pharmaceuticals
ATNM
$27M
$17.5K ﹤0.01%
13,890
ATOS icon
3214
Atossa Therapeutics
ATOS
$22.8M
$16.4K ﹤0.01%
1,159
MSGM icon
3215
Motorsport Games
MSGM
$18.2M
$16.4K ﹤0.01%
12,216
MKTW icon
3216
MarketWise
MKTW
$53.1M
$15.5K ﹤0.01%
1,368
STTK icon
3217
Shattuck Labs
STTK
$710M
$13.1K ﹤0.01%
10,860
VRCA icon
3218
Verrica Pharmaceuticals
VRCA
$86.2M
$8.54K ﹤0.01%
1,220
LYRA
3219
DELISTED
LYRA THERAPEUTICS INC
LYRA
$6.84K ﹤0.01%
662
AEYE icon
3220
AudioEye
AEYE
$70.8M
-9,380
Closed -$214K
AU icon
3221
AngloGold Ashanti
AU
$40.3B
-4,104
Closed -$1.88M
BTBT icon
3222
Bit Digital
BTBT
$484M
-96,480
Closed -$339K
COFS icon
3223
Choiceone Financial
COFS
$489M
-26,250
Closed -$811K
CRBP icon
3224
Corbus Pharmaceuticals
CRBP
$170M
-9,920
Closed -$205K
CTRN icon
3225
Citi Trends
CTRN
$524M
-507,247
Closed -$9.32M

Similar funds

AllianceBernstein's Q4 2024 Portfolio in Review

As of Q4 2024, AllianceBernstein held 3,298 positions worth $295B, down 1% from $298B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 4.4%. AllianceBernstein opened 67 new positions and exited 77, leaving the 3,298-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • AllianceBernstein's largest Q4 2024 buy was iShares iBoxx $ High Yield Corporate Bond ETF: 2,000,000 shares worth $157M.
  • AllianceBernstein added most to Cboe Global Markets in Q4 2024, an estimated $1.07B increase.
  • AllianceBernstein's biggest Q4 2024 reduction was Vertex Pharmaceuticals, cutting an estimated $1.6B.
  • AllianceBernstein fully exited iShares US Treasury Bond ETF in Q4 2024, selling an estimated $176M.
  • AllianceBernstein's ten largest holdings make up 30% of its $295B portfolio in Q4 2024.
  • AllianceBernstein opened 67 new positions and closed 77 in Q4 2024.
  • AllianceBernstein's portfolio value fell 1% quarter-over-quarter to $295B.

Based on AllianceBernstein's 13F filing for Q4 2024, filed 12 Feb 2025.